Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 6
2006 3
2007 6
2008 9
2009 5
2010 5
2011 10
2012 9
2013 13
2014 5
2015 10
2016 8
2017 9
2018 17
2019 16
2020 29
2021 16
2022 18
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
A case of dermatomyositis induced by SARS-CoV-2 infection.
Aimo C, Mariotti EB, Corrà A, Quintarelli L, Ruffo DI Calabria V, Bianchi B, Del Bianco E, Verdelli A, Benucci M, Caproni M. Aimo C, et al. Among authors: benucci m. Ital J Dermatol Venerol. 2024 Apr;159(2):214-215. doi: 10.23736/S2784-8671.24.07807-1. Epub 2024 Mar 4. Ital J Dermatol Venerol. 2024. PMID: 38436615 No abstract available.
ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study in Central-Italy.
D'Alessandro F, Cazzato M, Laurino E, Morganti R, Bardelli M, Frediani B, Buongarzone C, Moroncini G, Guiducci S, Cometi L, Benucci M, Ligobbi F, Marotto D, Mosca M. D'Alessandro F, et al. Among authors: benucci m. Clin Rheumatol. 2024 Feb;43(2):657-665. doi: 10.1007/s10067-023-06836-w. Epub 2023 Dec 23. Clin Rheumatol. 2024. PMID: 38135860 Free PMC article.
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists.
D'Angelo S, Atzeni F, Benucci M, Bianchi G, Cantini F, Caporali RF, Carlino G, Caso F, Cauli A, Ciccia F, D'Agostino MA, Dagna L, Dejaco C, Epis OM, Ferrucci MG, Franceschini F, Fusaro E, Gabini M, Gerli R, Giacomelli R, Govoni M, Gremese E, Guggino G, Iagnocco A, Iannone F, Laganà B, Lubrano E, Montecucco C, Peluso R, Ramonda R, Rossini M, Salvarani C, Sebastiani GD, Sebastiani M, Selmi C, Tirri E, Marchesoni A. D'Angelo S, et al. Among authors: benucci m. Front Med (Lausanne). 2023 Nov 30;10:1327931. doi: 10.3389/fmed.2023.1327931. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38098852 Free PMC article.
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D. Picchianti-Diamanti A, et al. Among authors: benucci m. Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684. Vaccines (Basel). 2023. PMID: 38006015 Free PMC article.
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain.
Infantino M, Foddai S, Manfredi M, Benucci M, Radin M, Cecchi I, Barinotti A, Aluf O, Rubini E, Elnaz R, Menegatti E, Roccatello D, Sciascia S. Infantino M, et al. Among authors: benucci m. Autoimmun Rev. 2023 Nov;22(11):103454. doi: 10.1016/j.autrev.2023.103454. Epub 2023 Sep 22. Autoimmun Rev. 2023. PMID: 37741530 No abstract available.
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters.
Cafaro G, Bartoloni E, Baldini C, Franceschini F, Riccieri V, Fioravanti A, Fornaro M, Ghirardello A, Palterer B, Infantino M, Rigon A, Del Rosso S, Gerli R, Villalta D, Bizzaro N; FIRMA (Interdisciplinary Forum for the Research on Autoimmune Diseases) Collaborators; FIRMA Collaborators. Cafaro G, et al. RMD Open. 2023 Sep;9(3):e003365. doi: 10.1136/rmdopen-2023-003365. RMD Open. 2023. PMID: 37734871 Free PMC article.
184 results